StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly earnings per share — Diluted ($) ($)

Annual figures from Eli Lilly's filings and investor materials

Latest, FY2025
22.95
Period ended Dec 31, 2025
Change on a year earlier
+96.0%
11.71 in FY2024
History
18 years
Since FY2008
Sources
16
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEarnings per share — Diluted ($) ($)Year on yearSource
FY2025Dec 31, 202522.95+96.0%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 202411.71+101.9%Form 10-K (filed 2025-02-19) ↗
FY2023Dec 31, 20235.80-15.9%Form 10-K (filed 2024-02-21) ↗
FY2022Dec 31, 20226.90+12.7%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 20216.12-9.9%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 20206.79-23.6%Form 10-K (filed 2021-02-17) ↗
FY2019Dec 31, 20198.89+184.0%Form 10-K (filed 2020-02-19) ↗
FY2018Dec 31, 20183.13-1,747.4%Form 10-K (filed 2019-02-19) ↗
FY2017Dec 31, 2017-0.19-107.4%Form 10-K (filed 2018-02-20) ↗
FY2016Dec 31, 20162.58+14.2%Form 10-K (filed 2017-02-21) ↗
FY2015Dec 31, 20152.26+1.3%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 20142.23-48.4%Form 10-K (filed 2015-02-19) ↗
FY2013Dec 31, 20134.32+18.0%Form 10-K (filed 2014-02-19) ↗
FY2012Dec 31, 20123.66-6.2%Form 10-K (filed 2013-02-21) ↗
FY2011Dec 31, 20113.90-14.8%Form 10-K (filed 2012-02-24) ↗
FY2010Dec 31, 20104.58+16.2%Form 10-K (filed 2011-02-22) ↗

Cite this data

StockData. (2026). Eli Lilly Earnings per share — Diluted ($) ($), annual FY2008–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_eps_diluted

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.